Haemonetics CORP 8-K filings
NYSE
Haemonetics Corporation has announced a definitive agreement to acquire Attune Medical for $160 million in cash upfront, plus contingent payments, to expand its presence in the electrophysiology market.
NYSE
Haemonetics Corporation announced positive third quarter fiscal 2024 results, with revenue growth and increased profitability, leading to an updated fiscal year guidance.